checkAd

     1373  0 Kommentare IonQ Announces First Quarter 2024 Financial Results

    IonQ (NYSE: IONQ), a leader in the quantum computing industry, today announced financial results for the quarter ended March 31, 2024.

    “We kicked the year off with strong revenue results, once again outperforming the high end of our guidance range,” said Peter Chapman, President and CEO of IonQ. “I am also pleased to announce that our sales pipeline is expanding significantly in deal size and volume and increasing in timing visibility, allowing us to raise our full year bookings guidance.”

    “The first quarter also saw several institutions, both public and private, use the power of our quantum computers to explore new projects. The start of the year also saw Oak Ridge National Labs, a returning client, begin research on a use case around energy schedule optimization for the United States national power grid. We believe we will continue to see new use cases unfold as our technology approaches commercial advantage.”

    Financial Highlights

    • IonQ recognized revenue of $7.6 million for the first quarter, which is above the high end of the previously provided range of $6.5 to $7.5 million, and represents 77% growth compared to $4.3 million in the prior year.
    • IonQ achieved $0.3 million in new bookings for the first quarter.
    • Cash, cash equivalents and investments were $434.4 million as of March 31, 2024.
    • Net loss was $39.6 million and Adjusted EBITDA loss was $27.0 million for the first quarter.* Exclusions from Adjusted EBITDA include a non-cash gain of $8.6 million related to the change in the fair value of IonQ’s warrant liabilities.

    *Adjusted EBITDA is a non-GAAP financial measure defined under “Non-GAAP Financial Measures,” and is reconciled to net loss, its closest comparable GAAP measure, at the end of this release.

    Commercial Highlights

    Corporate Highlights

    2024 Financial Outlook

    • For the full year 2024, IonQ expects revenue to be between $37 million and $41 million, with between $7.6 million and $9.2 million for the second quarter.
    • For the full year 2024, IonQ is increasing its bookings expectation range to between $75 million and $95 million.

    First Quarter 2024 Conference Call

    IonQ will host a conference call today at 4:30 p.m. Eastern time to review the Company’s financial results for the first quarter March 31, 2024 and to provide a business update. The call will be accessible by telephone at 877-407-4018 (domestic) or 201-689-8471 (international). The call will also be available live via webcast on the Company’s website here, or directly here. A telephone replay of the conference call will be available approximately three hours after its conclusion at 844-512-2921 (domestic) or 412-317-6671 (international) with access code 13745211 and will be available until 11:59 p.m. Eastern time, May 22, 2024. An archive of the webcast will also be available here shortly after the call and will remain available for one year.

    Upcoming Investor Conference Participation

    IonQ today announced that Thomas Kramer, Chief Financial Officer, and Jordan Shapiro, Vice President of FP&A and Head of Investor Relations, will participate in a fireside chat at the 19th Annual Needham Technology, Media, & Consumer Conference at the Westin Grand Central Hotel in New York City on Tuesday, May 14, 2024. The Company’s discussion will begin at 9:30 a.m. Eastern time and the webcast link will be available on IonQ’s website here, or directly here.

    Upcoming Technical Progress Presentation

    IonQ will host an exclusive live webinar tomorrow, May 9th, at 1 p.m. Eastern time where the technical leads will further discuss our latest technology advancements and updates. To sign up, please visit the registration page here.

    Non-GAAP Financial Measures

    To supplement IonQ’s condensed consolidated financial statements presented in accordance with GAAP, IonQ uses non-GAAP measures of certain components of financial performance. Adjusted EBITDA is a financial measure that is not required by or presented in accordance with GAAP. Management believes that this measure provides investors an additional meaningful method to evaluate certain aspects of the Company’s results period over period. Adjusted EBITDA is defined as net loss before interest income, net, interest expense, income tax expense, depreciation and amortization expense, stock-based compensation, change in fair value of assumed warrant liabilities, and other non-recurring non-operating income and expenses. IonQ uses Adjusted EBITDA to measure the operating performance of its business, excluding specifically identified items that it does not believe directly reflect its core operations and may not be indicative of recurring operations. The presentation of non-GAAP financial measures is not meant to be considered in isolation or as a substitute for the financial results prepared in accordance with GAAP, and IonQ’s non-GAAP measures may be different from non-GAAP measures used by other companies. For IonQ’s investors to be better able to compare the Company’s current results with those of previous periods, IonQ shows a reconciliation of GAAP to non-GAAP financial measures at the end of this release.

    About IonQ

    IonQ, Inc. is a leader in quantum computing that delivers high-performance systems capable of solving the world’s largest and most complex commercial and research use cases. IonQ’s current generation quantum computer, IonQ Forte, is the latest in a line of cutting-edge systems, boasting 36 algorithmic qubits. The Company’s innovative technology and rapid growth were recognized in Fast Company’s 2023 Next Big Things in Tech List and Deloitte’s 2023 Technology Fast 500 List, respectively. Available through all major cloud providers, IonQ is making quantum computing more accessible and impactful than ever before. Learn more at IonQ.com.

    IonQ Forward-Looking Statements

    This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Some of the forward-looking statements can be identified by the use of forward-looking words. Statements that are not historical in nature, including the words “anticipate,” “expect,” “suggests,” “plan,” “believe,” “intend,” “estimates,” “targets,” “projects,” “should,” “could,” “would,” “may,” “will,” “forecast” and other similar expressions are intended to identify forward-looking statements. These statements include those related to the Company’s technology driving commercial advantage in the future; the Company’s future financial and operating performance, including our preliminary outlook and guidance; the appearance of new applications of IonQ’s products and services; the ability for third parties to implement IonQ’s offerings to solve their problems and increase their quantum computing capabilities; expansion of IonQ’s sales pipeline; IonQ’s quantum computing capabilities and plans; future deliveries of and access to IonQ’s quantum computers; and the scalability and reliability of IonQ’s quantum computing offerings. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to: changes in the competitive industries in which IonQ operates, including development of competing technologies; our ability to sell effectively to government entities and large enterprises; changes in laws and regulations affecting IonQ’s business; IonQ’s ability to implement its business plans, forecasts and other expectations, to identify and realize partnerships and opportunities, and to engage new and existing customers; and risks associated with U.S. government sales, including availability of funding and provisions that allow the government to unilaterally terminate or modify contracts for convenience. You should carefully consider the foregoing factors and the other risks and uncertainties disclosed in the Company’s filings, including but not limited to those described in the “Risk Factors” section of IonQ’s most recent Annual Report on Form 10-K and other documents filed by IonQ from time to time with the Securities and Exchange Commission. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and IonQ assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. IonQ does not give any assurance that it will achieve its expectations.

    IonQ, Inc.
    Condensed Consolidated Statements of Operations
    (unaudited)
    (in thousands, except share and per share data)

     

     

     

    Three Months Ended
    March 31,

     

     

     

    2024

     

     

    2023

     

    Revenue

     

    $

    7,582

     

     

    $

    4,285

     

    Costs and expenses:

     

     

     

     

     

     

    Cost of revenue (excluding depreciation and amortization)

     

     

    3,414

     

     

     

    1,036

     

    Research and development

     

     

    32,368

     

     

     

    16,233

     

    Sales and marketing

     

     

    6,701

     

     

     

    2,667

     

    General and administrative

     

     

    14,020

     

     

     

    10,581

     

    Depreciation and amortization

     

     

    3,955

     

     

     

    1,791

     

    Total operating costs and expenses

     

     

    60,458

     

     

     

    32,308

     

    Loss from operations

     

     

    (52,876

    )

     

     

    (28,023

    )

    Gain (loss) on change in fair value of warrant liabilities

     

     

    8,627

     

     

     

    (3,610

    )

    Interest income, net

     

     

    4,799

     

     

     

    4,231

     

    Other income (expense), net

     

     

    (134

    )

     

     

    64

     

    Loss before income tax expense

     

     

    (39,584

    )

     

     

    (27,338

    )

    Income tax benefit (expense)

     

     

    (8

    )

     

     

     

    Net loss

     

    $

    (39,592

    )

     

    $

    (27,338

    )

    Net loss per share attributable to common stockholders—basic and diluted

     

    $

    (0.19

    )

     

    $

    (0.14

    )

    Weighted average shares used in computing net loss per share attributable to common stockholders—basic and diluted

     

     

    208,159,439

     

     

     

    200,112,855

     

    IonQ, Inc.
    Condensed Consolidated Balance Sheets
    (unaudited)
    (in thousands)

     

     

     

    March 31,

     

     

    December 31,

     

     

     

    2024

     

     

    2023

     

    Assets

     

     

     

     

     

     

    Current assets:

     

     

     

     

     

     

    Cash and cash equivalents

     

    $

    60,074

     

     

    $

    35,665

     

    Short-term investments

     

     

    315,276

     

     

     

    319,776

     

    Accounts receivable

     

     

    9,556

     

     

     

    11,467

     

    Prepaid expenses and other current assets

     

     

    25,022

     

     

     

    23,081

     

    Total current assets

     

     

    409,928

     

     

     

    389,989

     

    Long-term investments

     

     

    59,090

     

     

     

    100,489

     

    Property and equipment, net

     

     

    42,380

     

     

     

    37,515

     

    Operating lease right-of-use assets

     

     

    9,261

     

     

     

    4,613

     

    Intangible assets, net

     

     

    16,865

     

     

     

    15,077

     

    Goodwill

     

     

    726

     

     

     

    742

     

    Other noncurrent assets

     

     

    5,612

     

     

     

    5,155

     

    Total Assets

     

    $

    543,862

     

     

    $

    553,580

     

    Liabilities and Stockholders’ Equity

     

     

     

     

     

     

    Current liabilities:

     

     

     

     

     

     

    Accounts payable

     

    $

    5,852

     

     

    $

    5,599

     

    Accrued expenses

     

     

    10,541

     

     

     

    18,376

     

    Current portion of operating lease liabilities

     

     

    1,178

     

     

     

    710

     

    Unearned revenue

     

     

    16,742

     

     

     

    12,087

     

    Current portion of stock option early exercise liabilities

     

     

    392

     

     

     

    392

     

    Total current liabilities

     

     

    34,705

     

     

     

    37,164

     

    Operating lease liabilities, net of current portion

     

     

    14,452

     

     

     

    7,395

     

    Unearned revenue, net of current portion

     

     

    181

     

     

     

    447

     

    Stock option early exercise liabilities, net of current portion

     

     

    350

     

     

     

    448

     

    Warrant liabilities

     

     

    14,378

     

     

     

    23,004

     

    Other noncurrent liabilities

     

     

    27

     

     

     

    128

     

    Total liabilities

     

    $

    64,093

     

     

    $

    68,586

     

    Stockholders’ Equity:

     

     

     

     

     

     

    Common stock

     

    $

    21

     

     

    $

    20

     

    Additional paid-in capital

     

     

    873,133

     

     

     

    839,014

     

    Accumulated deficit

     

     

    (391,665

    )

     

     

    (352,073

    )

    Accumulated other comprehensive loss

     

     

    (1,720

    )

     

     

    (1,967

    )

    Total stockholders’ equity

     

     

    479,769

     

     

     

    484,994

     

    Total Liabilities and Stockholders’ Equity

     

    $

    543,862

     

     

    $

    553,580

     

    IonQ, Inc.
    Condensed Consolidated Statements of Cash Flows
    (unaudited)
    (in thousands)

     

     

     

    Three Months Ended
    March 31,

     

     

     

    2024

     

     

    2023

     

    Cash flows from operating activities:

     

     

     

     

     

     

    Net loss

     

    $

    (39,592

    )

     

    $

    (27,338

    )

    Adjustments to reconcile net loss to net cash used in operating activities:

     

     

     

     

     

     

    Depreciation and amortization

     

     

    3,955

     

     

     

    1,791

     

    Non-cash research and development arrangements

     

     

    130

     

     

     

    130

     

    Stock-based compensation

     

     

    22,061

     

     

     

    10,268

     

    (Gain) loss on change in fair value of warrant liabilities

     

     

    (8,627

    )

     

     

    3,610

     

    Amortization of premiums and accretion of discounts on available-for-sale securities

     

     

    (2,302

    )

     

     

    (1,915

    )

    Other, net

     

     

    809

     

     

     

    345

     

    Changes in operating assets and liabilities:

     

     

     

     

     

     

    Accounts receivable

     

     

    1,897

     

     

     

    2,044

     

    Prepaid expenses and other current assets

     

     

    (4,656

    )

     

     

    (939

    )

    Accounts payable

     

     

    (521

    )

     

     

    728

     

    Accrued expenses

     

     

    (554

    )

     

     

    920

     

    Unearned revenue

     

     

    4,389

     

     

     

    (3,271

    )

    Other assets and liabilities

     

     

    2,546

     

     

     

    (188

    )

    Net cash provided by (used in) operating activities

     

    $

    (20,465

    )

     

    $

    (13,815

    )

    Cash flows from investing activities:

     

     

     

     

     

     

    Purchases of property and equipment

     

     

    (3,140

    )

     

     

    (1,185

    )

    Capitalized software development costs

     

     

    (1,400

    )

     

     

    (843

    )

    Intangible asset acquisition costs

     

     

    (357

    )

     

     

    (318

    )

    Purchases of available-for-sale securities

     

     

    (66,619

    )

     

     

    (64,430

    )

    Maturities and sales of available-for-sale securities

     

     

    115,045

     

     

     

    88,091

     

    Net cash provided by (used in) investing activities

     

    $

    43,529

     

     

    $

    21,315

     

    Cash flows from financing activities:

     

     

     

     

     

     

    Proceeds from stock options exercised

     

     

    486

     

     

     

    52

     

    Tax withholding receipts (payments) related to vested and released RSUs, net

     

     

    873

     

     

     

    (18

    )

    Net cash provided by (used in) financing activities

     

    $

    1,359

     

     

    $

    34

     

    Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash

     

     

    4

     

     

     

     

    Net change in cash, cash equivalents and restricted cash

     

     

    24,427

     

     

     

    7,534

     

    Cash, cash equivalents and restricted cash at the beginning of the period

     

     

    38,081

     

     

     

    46,367

     

    Cash, cash equivalents and restricted cash at the end of the period

     

    $

    62,508

     

     

    $

    53,901

     

    IonQ, Inc.
    Reconciliation of Net Loss to Adjusted EBITDA
    (unaudited)
    (in thousands)

     

     

     

    Three Months Ended
    March 31,

     

     

     

    2024

     

     

    2023

     

    Net loss

     

    $

    (39,592

    )

     

    $

    (27,338

    )

    Interest income, net

     

     

    (4,799

    )

     

     

    (4,231

    )

    Interest expense

     

     

     

     

     

     

    Income tax benefit (expense)

     

     

    8

     

     

     

     

    Depreciation and amortization

     

     

    3,955

     

     

     

    1,791

     

    Stock-based compensation

     

     

    22,061

     

     

     

    10,268

     

    (Gain) loss on change in fair value of warrant liabilities

     

     

    (8,627

    )

     

     

    3,610

     

    Adjusted EBITDA

     

    $

    (26,994

    )

     

    $

    (15,900

    )

     


    The IonQ Stock at the time of publication of the news with a raise of +1,74 % to 8,78USD on NYSE stock exchange (08. Mai 2024, 21:59 Uhr).

    Diskutieren Sie über die enthaltenen Werte


    Business Wire (engl.)
    0 Follower
    Autor folgen

    IonQ Announces First Quarter 2024 Financial Results IonQ (NYSE: IONQ), a leader in the quantum computing industry, today announced financial results for the quarter ended March 31, 2024. “We kicked the year off with strong revenue results, once again outperforming the high end of our guidance range,” …